Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer
Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer
复制标题
DOI：
10.1200/op.20.00489
复制
发表时间：
2020-12-01
影响因子：
4
通讯作者：
Popat, Sanjay
中科院分区：
文献类型：
--
作者：
Cui, Wanyuan;Cotter, Chantal;Popat, Sanjay
